Global Veterinary Zinc Bacitracin Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Veterinary Zinc Bacitracin Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ918195 | No. of Pages: 137 | Category: Agriculture
Publisher: GRD Survey | Date of Publish: Sep-2021 
Executive Summary

According to GRD Survey data, the global Veterinary Zinc Bacitracin market was valued at  million US$ in 2020 and is expected to  million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Veterinary Zinc Bacitracin market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Veterinary Zinc Bacitracin in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    10% Zinc Bacitracin

    15% Zinc Bacitracin

    The production market share of 15% Zinc Bacitracin was larger than 10% Zinc Bacitracin slightly, which was accounted for 53.37% in 2018, and others were 15% Zinc Bacitracin.

Market Snapshot, By Application
    Pigs

    Cattle

    Chicken

    Others

    The segments, Cattle and Chicken, were two widest application in Zinc Bacitracin Consumption region, with market shares of 39% and 35% in 2018.

Market Snapshot, By Region:
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        South Africa
        Israel
        Turkey
        Saudi Arabia

Main Market Players Analyzed in this report, including:
    Zoetis

    Vega Pharma

    Tianjin Xinxing Veterinary Pharmaceutical

    Qilu Pharmaceutical

    Orion Animal Nutrition

    Lifecome Biochemistry

    Huvepharma

    Ceva Corporate


The study objectives of this report are:
    To study and analyze the global Veterinary Zinc Bacitracin market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Veterinary Zinc Bacitracin market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Veterinary Zinc Bacitracin manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Veterinary Zinc Bacitracin market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Veterinary Zinc Bacitracin submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Veterinary Zinc Bacitracin are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Veterinary Zinc Bacitracin Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Veterinary Zinc Bacitracin Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Veterinary Zinc Bacitracin

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Veterinary Zinc Bacitracin Sales Channel and Distributors Analysis
        3.3.1 Veterinary Zinc Bacitracin Sales Channel
        3.3.2 Veterinary Zinc Bacitracin Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Pigs

        3.4.2 Major Buyers in Cattle

    3.5 Veterinary Zinc Bacitracin Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Veterinary Zinc Bacitracin Type Introduction
        4.1.1 10% Zinc Bacitracin

        4.1.2 15% Zinc Bacitracin

        4.1.3 The production market share of 15% Zinc Bacitracin was larger than 10% Zinc Bacitracin slightly, which was accounted for 53.37% in 2018, and others were 15% Zinc Bacitracin.
    4.2 Global Veterinary Zinc Bacitracin Sales by Type 2016-2021
    4.3 Global Veterinary Zinc Bacitracin Revenue by Type 2016-2021
    4.4 Global Veterinary Zinc Bacitracin Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Veterinary Zinc Bacitracin Type Introduction
        5.1.1 Pigs

        5.1.2 Cattle

        5.1.3 Chicken

        5.1.3 Others

        5.1.4 The segments, Cattle and Chicken, were two widest application in Zinc Bacitracin Consumption region, with market shares of 39% and 35% in 2018.
    5.2 Global Veterinary Zinc Bacitracin Sales by Application 2016-2021
    5.3 Global Veterinary Zinc Bacitracin Revenue by Application 2016-2021
    5.4 Global Veterinary Zinc Bacitracin Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Veterinary Zinc Bacitracin Market by Region
        6.1.1 Global Veterinary Zinc Bacitracin Sales by Regions
        6.1.2 Global Veterinary Zinc Bacitracin Revenue by Regions
    6.2 North America Veterinary Zinc Bacitracin Market 2016-2021
    6.3 Europe Veterinary Zinc Bacitracin Market 2016-2021
    6.4 Asia Pacific Veterinary Zinc Bacitracin Market 2016-2021
    6.5 South America Veterinary Zinc Bacitracin Market 2016-2021
    6.6 Middle East and Africa Veterinary Zinc Bacitracin Market 2016-2021

7 North America
    7.1 North America Veterinary Zinc Bacitracin Market by Country 2016-2021
        7.1.1 North America Veterinary Zinc Bacitracin Sales by Country
        7.1.2 North America Veterinary Zinc Bacitracin Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Veterinary Zinc Bacitracin Market by Country 2016-2021
        8.1.1 Europe Veterinary Zinc Bacitracin Sales by Country
        8.1.2 Europe Veterinary Zinc Bacitracin Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Veterinary Zinc Bacitracin Market by Country 2016-2021
        9.1.1 Asia Pacific Veterinary Zinc Bacitracin Sales by Country
        9.1.2 Asia Pacific Veterinary Zinc Bacitracin Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Veterinary Zinc Bacitracin Market by Country 2016-2021
        10.1.1 South America Veterinary Zinc Bacitracin Sales by Country
        10.1.2 South America Veterinary Zinc Bacitracin Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Veterinary Zinc Bacitracin Market by Country 2016-2021
        11.1.1 Middle East and Africa Veterinary Zinc Bacitracin Sales by Country
        11.1.2 Middle East and Africa Veterinary Zinc Bacitracin Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Zoetis

        12.1.1 Zoetis
 Company Information
        12.1.2 Zoetis
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.1.3 Zoetis
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Zoetis
 Key Development
    12.2 Vega Pharma

        12.2.1 Vega Pharma
 Company Information
        12.2.2 Vega Pharma
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.2.3 Vega Pharma
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 Vega Pharma
 Key Development
    12.3 Tianjin Xinxing Veterinary Pharmaceutical

        12.3.1 Tianjin Xinxing Veterinary Pharmaceutical
 Company Information
        12.3.2 Tianjin Xinxing Veterinary Pharmaceutical
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.3.3 Tianjin Xinxing Veterinary Pharmaceutical
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Tianjin Xinxing Veterinary Pharmaceutical
 Key Development
    12.4 Qilu Pharmaceutical

        12.4.1 Qilu Pharmaceutical
 Company Information
        12.4.2 Qilu Pharmaceutical
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.4.3 Qilu Pharmaceutical
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Qilu Pharmaceutical
 Key Development
    12.5 Orion Animal Nutrition

        12.5.1 Orion Animal Nutrition
 Company Information
        12.5.2 Orion Animal Nutrition
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.5.3 Orion Animal Nutrition
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Orion Animal Nutrition
 Key Development
    12.6 Lifecome Biochemistry

        12.6.1 Lifecome Biochemistry
 Company Information
        12.6.2 Lifecome Biochemistry
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.6.3 Lifecome Biochemistry
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 Lifecome Biochemistry
 Key Development
    12.7 Huvepharma

        12.7.1 Huvepharma
 Company Information
        12.7.2 Huvepharma
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.7.3 Huvepharma
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 Lifecome Biochemistry
 Key Development
        12.8.1 Ceva Corporate
 Company Information
        12.8.2 Ceva Corporate
 Veterinary Zinc Bacitracin Product Portfolio, Specification and Application
        12.8.3 Ceva Corporate
 Veterinary Zinc Bacitracin Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Ceva Corporate
 Key Development

13 Global Veterinary Zinc Bacitracin Market Forecast by Region by Type and by Application
    13.1 Global Veterinary Zinc Bacitracin Sales, Revenue Forecast 2022-2027
    13.2 Global Veterinary Zinc Bacitracin Forecast by Regions
        13.2.1 Global Veterinary Zinc Bacitracin Sales Forecast by Region 2022-2027
        13.2.2 Global Veterinary Zinc Bacitracin Revenue Forecast by Region 2022-2027
    13.3 Global Veterinary Zinc Bacitracin Forecast by Type
        13.3.1 Global Veterinary Zinc Bacitracin Sales Forecast by Type 2022-2027
        13.3.2 Global Veterinary Zinc Bacitracin Revenue Forecast by Type 2022-2027
        13.3.3 Global Veterinary Zinc Bacitracin Price Forecast by Type 2022-2027
    13.4 Global Veterinary Zinc Bacitracin Forecast by Application
        13.4.1 Global Veterinary Zinc Bacitracin Sales Forecast by Application 2022-2027
        13.4.2 Global Veterinary Zinc Bacitracin Revenue Forecast by Application 2022-2027
        13.4.3 Global Veterinary Zinc Bacitracin Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com